Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorey

Showing results (931-940 of 995) with videos related to

Pageof 100
Sort By:
Schizophrenia Research|November 22, 2015
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ datasetF Berna, D Misdrahi, L Boyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 25, 2022
Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort studyG Fond, J Dubreucq, P L Sunhary de Verville, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 9, 2017
Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ datasetRomain Rey, Thierry D'Amato, Laurent Boyer, et al.
Schizophrenia Research|August 11, 2015
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohortO Godin, M Leboyer, A Gaman, et al.
Schizophrenia Research|January 23, 2017
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohortM Andrianarisoa, L Boyer, O Godin, et al.
The Journal of Clinical Psychiatry|September 27, 2018
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ CohortOphélia Godin, Marion Leboyer, Frank Schürhoff, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 2, 2021
Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohortG Fond, P L Sunhary de Verville, R Richieri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 15, 2019
Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ)Ophelia Godin, Guillaume Fond, Ewa Bulzacka, et al.
Psychopharmacology|December 4, 2015
Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ datasetG Fond, L Boyer, M Favez, et al.
Brain and Behavior|January 8, 2020
Early and very early-onset schizophrenia compared with adult-onset schizophrenia: French FACE-SZ databaseNathalie Coulon, Ophélia Godin, Ewa Bulzacka, et al.
Pageof 100

Showing results (931-940 of 995) with videos related to

Sort By:
Pageof 100
Schizophrenia Research|November 22, 2015
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ datasetF Berna, D Misdrahi, L Boyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 25, 2022
Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort studyG Fond, J Dubreucq, P L Sunhary de Verville, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 9, 2017
Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ datasetRomain Rey, Thierry D'Amato, Laurent Boyer, et al.
Schizophrenia Research|August 11, 2015
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohortO Godin, M Leboyer, A Gaman, et al.
Schizophrenia Research|January 23, 2017
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohortM Andrianarisoa, L Boyer, O Godin, et al.
The Journal of Clinical Psychiatry|September 27, 2018
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ CohortOphélia Godin, Marion Leboyer, Frank Schürhoff, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 2, 2021
Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohortG Fond, P L Sunhary de Verville, R Richieri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 15, 2019
Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ)Ophelia Godin, Guillaume Fond, Ewa Bulzacka, et al.
Psychopharmacology|December 4, 2015
Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ datasetG Fond, L Boyer, M Favez, et al.
Brain and Behavior|January 8, 2020
Early and very early-onset schizophrenia compared with adult-onset schizophrenia: French FACE-SZ databaseNathalie Coulon, Ophélia Godin, Ewa Bulzacka, et al.
Pageof 100